Literature DB >> 12213710

Regulation of angiogenesis by vascular endothelial growth factor and angiopoietin-1 in the rat aorta model: distinct temporal patterns of intracellular signaling correlate with induction of angiogenic sprouting.

Wen-Hui Zhu1, Angela MacIntyre, Roberto Francesco Nicosia.   

Abstract

Vascular endothelial growth factor (VEGF) and angiopoietin-1 (Ang-1) promote the spontaneous angiogenic response of freshly cut rat aortic rings. When VEGF and Ang-1 were tested in cultures of 14-day-old rings, which are quiescent and unable to spontaneously produce neovessels, only VEGF was capable of inducing an angiogenic response. Ang-1 failed to initiate angiogenesis in this system, but significantly potentiated VEGF-induced neovessel sprouting. Potential differences in cell signaling triggered by VEGF and Ang-1 were evaluated in cultures of quiescent rings. VEGF induced biphasic and prolonged (15 minutes and 4 to 24 hours) phosphorylation of p44/42 MAPK and Akt, while the effect of Ang-1 was transient and monophasic (15 minutes). Both VEGF and Ang-1 induced rapid, monophasic (15 minutes) phosphorylation of p38 MAPK. When VEGF and Ang-1 were administered together, the second peak of VEGF-induced p44/42 MAPK phosphorylation was markedly reduced. The effect of the VEGF/Ang-1 combination on AKT phosphorylation was, instead, additive over time, and sustained over a 24-hour period. The VEGF/Ang-1 combination caused an additive effect also on p38 MAPK phosphorylation at 1 hour. Confocal microscopy of VEGF-, Ang-1, or VEGF/Ang-1-stimulated aortic rings double stained at time points of maximal phosphorylation for cell markers and signal transduction proteins demonstrated phosphorylated p44/42 MAPK, p38 MAPK, and Akt predominantly in endothelial cells. Experiments with specific inhibitors demonstrated that p44/42 MAPK and Akt, but not p38 MAPK, are necessary for neovessel sprouting. These results identify p44/42 MAPK and Akt as critical intracellular mediators of angiogenesis, whose transient phosphorylation is, however, not sufficient for the initiation of this process. The observation that sustained phosphorylation of these signaling pathways, particularly of Akt, correlates with induction of angiogenesis suggests that the duration of phosphorylation signals influences critical cellular events required for the induction of angiogenic sprouting.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213710      PMCID: PMC1867259          DOI: 10.1016/S0002-9440(10)64242-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  Vascular endothelial growth factor and the angiopoietins: working together to build a better blood vessel.

Authors:  K G Peters
Journal:  Circ Res       Date:  1998-08-10       Impact factor: 17.367

2.  Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy.

Authors:  D R DeSilva; E A Jones; M F Favata; B D Jaffee; R L Magolda; J M Trzaskos; P A Scherle
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

3.  Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models.

Authors:  J R Jackson; B Bolognese; L Hillegass; S Kassis; J Adams; D E Griswold; J D Winkler
Journal:  J Pharmacol Exp Ther       Date:  1998-02       Impact factor: 4.030

4.  Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.

Authors:  C Suri; P F Jones; S Patan; S Bartunkova; P C Maisonpierre; S Davis; T N Sato; G D Yancopoulos
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

5.  Endogenous regulation of angiogenesis in the rat aorta model. Role of vascular endothelial growth factor.

Authors:  R F Nicosia; Y J Lin; D Hazelton; X Qian
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

6.  p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.

Authors:  S Rousseau; F Houle; J Landry; J Huot
Journal:  Oncogene       Date:  1997-10       Impact factor: 9.867

7.  Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site.

Authors:  P R Young; M M McLaughlin; S Kumar; S Kassis; M L Doyle; D McNulty; T F Gallagher; S Fisher; P C McDonnell; S A Carr; M J Huddleston; G Seibel; T G Porter; G P Livi; J L Adams; J C Lee
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

8.  Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.

Authors:  T Asahara; D Chen; T Takahashi; K Fujikawa; M Kearney; M Magner; G D Yancopoulos; J M Isner
Journal:  Circ Res       Date:  1998-08-10       Impact factor: 17.367

9.  Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation.

Authors:  H P Gerber; A McMurtrey; J Kowalski; M Yan; B A Keyt; V Dixit; N Ferrara
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

10.  Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2.

Authors:  B Witzenbichler; P C Maisonpierre; P Jones; G D Yancopoulos; J M Isner
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

View more
  32 in total

1.  Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment.

Authors:  Hanako Kobayashi; Laura M DeBusk; Yael O Babichev; Daniel J Dumont; Pengnian Charles Lin
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

2.  Expressions of survivin and vascular endothelial growth factor in a Murine model of proliferative retinopathy.

Authors:  Na Cai; Ning-Ning Liu; Ning Zhao; Chao Wan; Yue-Dong Hu; Yun Zhou; Lei Chen
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

Review 3.  Selective Raf inhibition in cancer therapy.

Authors:  Vladimir Khazak; Igor Astsaturov; Ilya G Serebriiskii; Erica A Golemis
Journal:  Expert Opin Ther Targets       Date:  2007-12       Impact factor: 6.902

Review 4.  Phytochemicals for the Prevention of Photocarcinogenesis.

Authors:  Mary K Montes de Oca; Ross L Pearlman; Sarah F McClees; Rebecca Strickland; Farrukh Afaq
Journal:  Photochem Photobiol       Date:  2017-03-14       Impact factor: 3.421

Review 5.  Angiogenesis in the human corpus luteum.

Authors:  Norihiro Sugino; Aki Matsuoka; Ken Taniguchi; Hiroshi Tamura
Journal:  Reprod Med Biol       Date:  2008-04-17

6.  Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006).

Authors:  Danielle A Murphy; Sosina Makonnen; Wiem Lassoued; Michael D Feldman; Christopher Carter; William M F Lee
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

7.  Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease.

Authors:  Nicole L Ward; Alexandra L Haninec; Paul Van Slyke; John G Sled; Celina Sturk; R Mark Henkelman; Ian R Wanless; Daniel J Dumont
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

8.  Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulation.

Authors:  Edward M Conway; Femke Zwerts; Veerle Van Eygen; Astrid DeVriese; Nobuo Nagai; Wei Luo; Désiré Collen
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

9.  Tie2 in tumor endothelial signaling and survival: implications for antiangiogenic therapy.

Authors:  Jeff H Tsai; William M F Lee
Journal:  Mol Cancer Res       Date:  2009-03-10       Impact factor: 5.852

10.  Effect of angiogenesis induced by consecutive intramuscular injections of vascular endothelial growth factor in a hindlimb ischemic mouse model.

Authors:  Tai Kyoung Lee; Hyosook Hwang; Kyung Sook Na; JeongIl Kwon; Hwan-Seok Jeong; Philsun Oh; Hee Kwon Kim; Seok Tae Lim; Myung-Hee Sohn; Hwan-Jeong Jeong; Chang-Moon Lee
Journal:  Nucl Med Mol Imaging       Date:  2014-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.